{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:43:49Z","timestamp":1769553829380,"version":"3.49.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.02822","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T04:38:34Z","timestamp":1542775114000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Risk Assessment of Etanercept in Mice Chronically Infected With Toxoplasma gondii"],"prefix":"10.3389","volume":"9","author":[{"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junlong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2018,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.4049\/jimmunol.144.7.2725","article-title":"Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine.","volume":"144","author":"Adams","year":"1990","journal-title":"J. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jim.2017.03.023","article-title":"An oral administration of a recombinant anti-TNF fusion protein is biologically active in the gut promoting regulatory T cells: results of a phase I clinical trial using a novel oral anti-TNF alpha-based therapy.","volume":"446","author":"Almon","year":"2017","journal-title":"J. Immunol. Methods"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1172\/jci28796","article-title":"CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes.","volume":"116","author":"Andrade","year":"2006","journal-title":"J. Clin. Invest."},{"key":"B4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/2229-5070.190817","article-title":"Toxoplasmosis in HIV infection: an overview.","volume":"6","author":"Basavaraju","year":"2016","journal-title":"Trop. Parasitol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1128\/ec.00343-12","article-title":"Bradyzoite pseudokinase 1 is crucial for efficient oral infectivity of the Toxoplasma gondii tissue cyst.","volume":"12","author":"Buchholz","year":"2013","journal-title":"Eukaryot. Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1111\/j.1471-4159.2007.04928.x","article-title":"Immunomodulatory effects of etanercept in a model of brain injury act through attenuation of the acute-phase response.","volume":"103","author":"Campbell","year":"2007","journal-title":"J. Neurochem."},{"key":"B7","first-page":"33","article-title":"Role of TNF and IL-1 in infections with Toxoplasma gondii.","volume":"69","author":"Chang","year":"1990","journal-title":"Immunology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1051\/parasite\/2018014","article-title":"Extracts of Tectona grandis and Vernonia amygdalina have anti-Toxoplasma and pro-inflammatory properties in vitro.","volume":"25","author":"Degbe","year":"2018","journal-title":"Parasite"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108329","article-title":"Diagnostic value of a Rec-ELISA using Toxoplasma gondii recombinant SporoSAG, BAG1, and GRA1 proteins in murine models infected orally with tissue cysts and oocysts.","volume":"9","author":"Doskaya","year":"2014","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1017\/s0031182012000765","article-title":"Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology.","volume":"139","author":"Dubey","year":"2012","journal-title":"Parasitology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s12639-015-0712-y","article-title":"In vivo effect of anti-TNF agent (etanercept) in reactivation of latent toxoplasmosis.","volume":"40","author":"El-Sayed","year":"2016","journal-title":"J. Parasit. Dis."},{"key":"B12","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.4049\/jimmunol.173.5.3366","article-title":"Inhibition of the growth of Toxoplasma gondii in immature human dendritic cells is dependent on the expression of TNF-alpha receptor 2.","volume":"173","author":"Giese","year":"2004","journal-title":"J. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00277-003-0705-2","article-title":"Cerebral toxoplasmosis following etanercept treatment for idiophatic pneumonia syndrome after autologous peripheral blood progenitor cell transplantation (PBPCT).","volume":"82","author":"Gonzalez-Vicent","year":"2003","journal-title":"Ann. Hematol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/B978-0-444-53490-3.00008-X","article-title":"Toxoplasmosis.","volume":"114","author":"Halonen","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1293\/tox.2017-0031","article-title":"Quantitative analysis of histopathological findings using image processing software.","volume":"30","author":"Horai","year":"2017","journal-title":"J. Toxicol. Pathol."},{"key":"B16","first-page":"113","article-title":"Cells and cytokines in resistance to Toxoplasma gondii.","volume":"219","author":"Hunter","year":"1996","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"B17","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1128\/IAI.60.5.1979-1983.1992","article-title":"A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection.","volume":"60","author":"Johnson","year":"1992","journal-title":"Infect. Immun."},{"key":"B18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10165-011-0500-1","article-title":"Etanercept for the treatment of intractable hemophagocytic syndrome with systemic lupus erythematosus.","volume":"22","author":"Kikuchi","year":"2012","journal-title":"Mod. Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.hoc.2010.11.009","article-title":"Infectious complications associated with immunomodulating biologic agents.","volume":"25","author":"Koo","year":"2011","journal-title":"Hematol. Oncol. Clin. North. Am."},{"key":"B20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00436-006-0306-9","article-title":"Subversion of innate and adaptive immune responses by Toxoplasma gondii.","volume":"100","author":"Lang","year":"2007","journal-title":"Parasitol. Res."},{"key":"B21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4049\/jimmunol.148.2.568","article-title":"IFN-gamma-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-alpha.","volume":"148","author":"Langermans","year":"1992","journal-title":"J. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.semarthrit.2006.08.004","article-title":"Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis.","volume":"36","author":"Lassoued","year":"2007","journal-title":"Semin. Arthritis Rheum."},{"key":"B23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2147\/ijn.s151110","article-title":"Characterization of exosomes derived from Toxoplasma gondii and their functions in modulating immune responses.","volume":"13","author":"Li","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-015-0902-2","article-title":"Chungsimyeonja-eum inhibits inflammatory responses in RAW 264.7 macrophages and HaCaT keratinocytes.","volume":"15","author":"Lim","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"key":"B25","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0020-7519(03)00092-4","article-title":"Reduced expression of the inducible nitric oxide synthase after infection with Toxoplasma gondii facilitates parasite replication in activated murine macrophages.","volume":"33","author":"Luder","year":"2003","journal-title":"Int. J. Parasitol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jprot.2017.03.012","article-title":"iTRAQ-based differential proteomic analysis in Mongolian gerbil brains chronically infected with Toxoplasma gondii.","volume":"160","author":"Lv","year":"2017","journal-title":"J. Proteomics"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.meegid.2011.05.003","article-title":"Human impact on genetic diversity of Toxoplasma gondii: example of the anthropized environment from French Guiana.","volume":"11","author":"Mercier","year":"2011","journal-title":"Infect. Genet. Evol."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00298","article-title":"Immune activation and collateral damage in AIDS pathogenesis.","volume":"4","author":"Miedema","year":"2013","journal-title":"Front. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1111\/j.1471-4159.2008.05238.x","article-title":"Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis.","volume":"105","author":"Mishra","year":"2008","journal-title":"J. Neurochem."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/pim.12393","article-title":"Resiniferatoxin lowers TNF-alpha, NO and PGE2 in the intestinal phase and the parasite burden in the muscular phase of Trichinella spiralis infection.","volume":"39","author":"Munoz-Carrillo","year":"2017","journal-title":"Parasite Immunol."},{"key":"B31","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.ijpara.2009.02.001","article-title":"On a leishman body infection (or related organisms) of the gondii. 1908.","volume":"39","author":"Nicolle","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","article-title":"Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis.","volume":"39","author":"Pappas","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1128\/mmbr.00027-15","article-title":"Long-Term Relationships: the complicated interplay between the host and the developmental stages of Toxoplasma gondii during acute and chronic infections.","volume":"79","author":"Pittman","year":"2015","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.parint.2013.02.003","article-title":"Incidence of Toxoplasma retinochoroiditis in patients with ankylosing spondylitis after using TNF-alpha blockers.","volume":"62","author":"Rodrigues","year":"2013","journal-title":"Parasitol. Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1073\/pnas.1315156111","article-title":"Toxoplasma aldolase is required for metabolism but dispensable for host-cell invasion.","volume":"111","author":"Shen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ophtha.2010.04.020","article-title":"Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis.","volume":"118","author":"Soheilian","year":"2011","journal-title":"Ophthalmology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1056\/nejm199901283400401","article-title":"A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.","volume":"340","author":"Weinblatt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12794","article-title":"Functional analysis of Toxoplasma lactate dehydrogenases suggests critical roles of lactate fermentation for parasite growth in vivo.","volume":"20","author":"Xia","year":"2018","journal-title":"Cell. Microbiol."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.02210","article-title":"ANK1 and DnaK-TPR, two tetratricopeptide repeat-containing proteins primarily expressed in Toxoplasma bradyzoites, do not contribute to bradyzoite differentiation.","volume":"8","author":"Yang","year":"2017","journal-title":"Front. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jep.2017.02.013","article-title":"The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activation.","volume":"200","author":"Yang","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1093\/infdis\/jiu179","article-title":"Etanercept reduces neuroinflammation and lethality in mouse model of Japanese encephalitis.","volume":"210","author":"Ye","year":"2014","journal-title":"J. Infect. Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/jbmr.2125","article-title":"Etanercept administration to neonatal SH3BP2 knock-in cherubism mice prevents TNF-alpha-induced inflammation and bone loss.","volume":"29","author":"Yoshitaka","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1056\/NEJMc051556","article-title":"Infliximab and reactivation of cerebral toxoplasmosis.","volume":"353","author":"Young","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00383-013-3415-4","article-title":"Beneficial effects of Etanercept on experimental necrotizing enterocolitis.","volume":"30","author":"Yurttutan","year":"2014","journal-title":"Pediatr. Surg. Int."},{"key":"B45","first-page":"S34","article-title":"Immunological basis for the use of TNFalpha-blocking agents in ankylosing spondylitis and immunological changes during treatment.","volume":"20","author":"Zou","year":"2002","journal-title":"Clin. Exp. Rheumatol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.02822\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T10:10:34Z","timestamp":1694081434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.02822\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,21]]},"references-count":45,"alternative-id":["10.3389\/fmicb.2018.02822"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.02822","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,21]]},"article-number":"2822"}}